Energy augmentation structures, energy emitters or energy collectors containing the same, and their use in solar cells and other energy conversion devices
US-2024115878-A1 · Apr 11, 2024 · US
US10335487B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10335487-B2 |
| Application number | US-201615578218-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 15, 2016 |
| Priority date | Jun 19, 2015 |
| Publication date | Jul 2, 2019 |
| Grant date | Jul 2, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention presents methods for targeting and killing types of cells or organisms using Magneto-Electric Nano-Particles under the control of an external magnetic field. A method was also presented for using Magneto-Electric Nano-Particles to stimulate or rejuvenate cells under an external magnetic field.
Opening claim text (preview).
I claim: 1. A method for targeting cells that are less negatively charged than surrounding cells comprising injecting a solution of nano-particles at an area, wherein the nano-particles are Magneto-Electric Nano-Particles (MENPs), increasing negative charges of the nano-particles so as to produce an electric gradient field, which is accomplished by applying for a period of time an external field on the MENPs; and the electric gradient field pushing or driving the nano-particles from the area toward the less negatively charged cells; wherein the method further comprises (1) placing, injecting or implanting one or more permanent magnets or electro-magnets in a cancer site, wherein the magnets) serves to attract MENPs to and increase accumulation of MENPs in the cancer site, as well as to increase the negative charges of the MENPs to steer the MENPs towards cancer cells; (2) injecting or implanting wires, liquid capsules, injectable macro-particles, made of permanent magnetic material into a solid tumor site that is inside a body or an organ, wherein the magnetic field produced by these injected or implanted magnetic sources serve to localize and accumulate the MENPs at cancer sites, and at the same time to enhance the electric field gradient to push MENPs to cancer cells; or (3) using an apparatus formed into a shape and dimension to fit a target area or volume that is made of or using permanent magnetic material and with one or more electromagnets embedded in the apparatus to generate a constant magnetic field and a changing magnetic field simultaneously. 2. The method in claim 1 wherein the MENPs are made with a basic structure of CoFe 2 O 4 —BaTiO 3 coreshell. 3. The method in claim 2 wherein the nano-particles are further surface functionalized by a compound. 4. The method in claim 1 further comprising using an external field to guide and/or enhance an accumulation of the nano-particles into a site containing the less negatively charged cells than the surrounding more negatively charged cells. 5. The method in claim 2 wherein the external field comprises a magnetic field that is a changing field generating a varying or pulsating force to push MENPs towards less negatively charged cells. 6. The method in claim 5 wherein the changing magnetic field is generated by driving a periodic or irregular alternating current through one or more electro-magnets, or by varying position of one or more permanent magnets. 7. The method in claim 6 further comprising changing period, pattern, magnitude and/or direction of an alternating magnetic field to achieve desired movements of the MENPs. 8. The method in claim 1 , wherein the increasing of the negative charges of the nano-particles is accomplished by using nano-particles that are made of a chemical composition that produces a negative surface charge or are coated or conjugated with molecules that increase the negative surface charge when they are in a blood stream or body fluid.
Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title
Inorganic compounds · CPC title
for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body (electrodes for external use A61N1/0428) · CPC title
using magnetic fields produced by coils, including single turn loops or electromagnets (A61N2/12 takes precedence) · CPC title
using magnetic fields produced by permanent magnets (A61N2/12 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.